banner
LXR inhibitor, LXRβ agonist-2, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM254

LXR inhibitor, LXRβ agonist-2, Purity ≥98%

Synonym: 1949801-52-8; LXR|A agonist-2; HY-100469; CS-0019108; (5S)-3-[2-[4-[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)-2-propylphenoxy]-2-hydroxyphenyl]-2-oxoethyl]-5-methyl-5-(5-propan-2-yloxypyridin-2-yl)imidazolidine-2,4-dione; LXR inhibitor

  • CAS Number: 1949801-52-8
  • Compound CID: 132508419
img
Product Size
1 mg; 5 mg; 10 mg; 20 mg
Price
Datasheet
MSDS
Properties
Description
LXRβ agonist-2 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting LXR. The molecular weight of the compound is 683.59, and its molecular formula is C32H31F6N3O7.
Molecular Weight
683.59
Molecular Formula
C32H31F6N3O7
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
LXRβ agonist-2 can be used for its potential implications for managing dyslipidemia and atherosclerosis.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0